|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
5/6/2010 11:18:14 AM
REUTLINGEN, Germany--(BUSINESS WIRE)--Retina Implant, AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of findings from their first clinical trial in which blind patients were able to view and focus on objects as their eye and head naturally moved as opposed to needing to constantly move their head to scan a scene, which is the case for other implants in which a camera is mounted to the patient’s head. The presentation delivered by lead author, Professor Eberhart Zrenner, M.D., director and chairman of the Institute for Ophthalmic Research at the Center for Ophthalmology of the University of Tuebingen, Germany, is one of twelve Retina Implant-related presentations being presented at the 2010 Association for Research in Vision and Ophthalmology (ARVO) annual meeting convening May 2-6 in Fort Lauderdale, Fla.
|
|
|
|
|
|
|
|
|
|
|